Seoul
South Korea
7
2022-09-01
6
2024-03-19
These are the the leading inventors for applications assigned to STCUBE, INC.:
STCUBE, INC. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
ANTIBODIES SPECIFIC TO GLYCOSYLATED PD-L1 AND METHODS OF USE THEREOF
#2 | 2022-05-19 ✅ Patent 11,933,786 granted on 2024-03-19Antibodies specific to glycosylated PD-L1 and methods of use thereof
#3 | 2021-05-13 ✅ Patent 11,981,736 granted on 2024-05-14Antibodies specific to glycosylated PD-1 and methods of use thereof
#4 | 2019-07-18 ✅ Patent 11,746,152 granted on 2023-09-05Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1
#5 | 2019-03-21 ✅ Patent 11,660,352 granted on 2023-05-30Dual function antibodies specific to glycosylated PD-L1 and methods of use thereof
#6 | 2019-03-14 ✅ Patent 10,858,432 granted on 2020-12-08Antibodies specific to glycosylated PD-1 and methods of use thereof
#7 | 2018-05-03 ✅ Patent 10,836,827 granted on 2020-11-17Antibodies specific to glycosylated PD-L1 and methods of use thereof
Also check out STCUBE, INC.'s (Seoul, South Korea) applicant profile with 6 patent applications submitted.
134571 ⎘